Abstract
Introduction

Doxorubicin (DOX) is a highly effective anthracycline anticancer drug that has been used for more than four decades to treat a variety of human neoplasms
. The well-recognized cardiotoxic side effect of DOX, which may lead to irreversible dilated cardiomyopathy and heart failure [2, 3] 
has been a dilemma for both oncologists and cardiologists around the world and seriously limited its use in the treatment of many cancer patients. Despite intensive research in the past decades, an optimal therapeutic intervention for protecting heart against DOX-induced cytotoxicity has not been identified. Dexrazoxane is the only compound currently approved by U.S. Food and Drug Administration in September 2007 for protection against anthracycline-induced tissue injuries such as extravasation.
However, due to the cytotoxic side effect and limited efficacy of dexrazoxane, there is an ongoing need for a better drug for protecting heart against DOX-induced cardiotoxicity [4] .
The cardioprotective role of nitric oxide has been demonstrated in numerous animal models of myocardial damage such as ischemia-reperfusion injury [5] [6] [7] [8] . The nitrate/nitrite/nitric oxide pathway is a crucial complementary or alternative system to the nitric oxide synthase dependent pathway for ensuring sufficient nitric oxide production, especially under pathophysiological conditions such as hypoxia and acidosis when the oxygen-dependent NOS activities are compromised [9, 10] . As a substantial portion of nitrate/nitrite in the body is derived from dietary sources, dietary supplementation of nitrate or nitrite was shown to attenuate myocardial ischemia-reperfusion injury [11, 12] and hypertension [13, 14] . We recently showed the protective effects of chronic oral nitrate intake against DOX-induced cardiac contractile dysfunction, myocyte necrosis/apoptosis and mitochondrial respiratory chain damages [15, 16] . To further explore the molecular mechanisms underlying nitrate-induced protection against DOX cardiotoxicity,
Protocol for animal experiments
The mice were administered a single dose of DOX intraperitoneally (15 8 and continued through the end of 5-day post-DOX period as described previously [15, 16] . Such nitrate supplementation protocol has been shown to protect against DOX-induced ventricular dysfunction [15] and mitochondrial respiratory chain damage [16] . Under surgical anaesthesia with pentobarbital sodium (70 mg/kg, i.p.), the heart samples were collected via thoractomy, rinsed off blood with saline and immediately frozen in liquid nitrogen and stored at -70ЊC until further proteomic experiments or Western blot analysis. Figure 2 is a typical example of Figure 3 (Fig. 5) .
Two-dimensional differential in-gel electrophoresis and minimal CyDye labelling
Results
Detection of DOX-induced alterations in cardiac protein expression with 2D-DIGE
Fig. 1 Scanned images of the 2D gels. (A) Overlay image for in-gel comparison between hearts from Control (labelled in green dye) and DOXtreated (labelled in red dye) mice; (B) Overlay image for in-gel comparison between Control heart (labelled in green dye) and heart sample from mouse that received nitrate supplementation plus DOX injection (Nitrate ϩ DOX; labelled in red dye). The circled and numbered protein spots (82 in total with a cut-off ratio of 1.5 for alteration in protein expression among the three treatment conditions) are subsequently isolated from the gels and identified by MALDI TOF/TOF mass spectroscopy.
DOX-induced modifications in protein expression (top panel), i.e. up-regulation at protein spot #21 and #25 versus down-regulation at spot #23. It is quite obvious that DOX-induced change in colour of these spots is normalized by nitrate supplementation (see the lower panel). A representative image of individual protein spot (#73) is shown in
Classification of DOX-modified protein expression based on biological function
To further understand the functional significance of DOX-modified proteins in the heart, we grouped positively identified proteins according to their known biological functions (
Western blot analysis for verification of 2D-DIGE results
To confirm the 2D-DIGE results, DOX-induced six prominently modified proteins with known functional significance were probed by Western blots. These included antioxidant enzymes (SOD2,
Prx3, Prx5), cytoskeletal/contractile protein (MYL2) and metabolic protein (FABP3, PYGB). To a larger extent, Western blot results confirmed most of the changes detected by 2D-DIGE for PYGB, SOD2, Prx3 and Prx5 (Figs 5 and 6). In contrast, two proteins (MYL2 and FABP3) showed opposite trend of the 2D-DIGE proteomic analysis
Effect of nitrate supplementation on mortality
As shown in Figure 7, [19] and others [20] . Because the protective role of SOD2 against DOX-induced cardiac injury has been well established by transgenic mice overexpressing SOD2 [21, 22] , the up-regulation of SOD2 in the hearts from DOX-treated mice appears to be an adaptive response to DOX. However, the observed adaptive induction of cardiac SOD2 by DOX [19, 20] was not sufficient to prevent the DOX-induced cardiac ROS generation [23] and dysfunction [15] . The normalization of cardiac SOD2 expression by nitrate supplementation is likely due to the reduced level of oxidative stress following nitrate treatment that we recently reported [23] . Similarly, an increase of Prx3 was previously reported by Merten et al. [20] . Nitrate [30, 31] , only limited studies have used proteomic approaches which were specifically targeted toward comparing the protein abundance between the DOX treatment with or without the cardioprotective intervention [20, [32] [33] [34] [35] [36] , including transgenic overexpression of metallothionein [20] , heat shock preconditioning [35] and co-treatment with docetaxel [33] . To [40, 41] . Nitrate intake has been shown to exert a number of beneficial effects to attenuate myocardial ischemia-reperfusion injury [11, 12] , hypertension [13, 14] and platelet aggregation [38] . In addition, nitrate supplementation has been shown to alleviate other degenerative chronic diseases such as type-2 diabetes [42] , decreasing whole body oxygen cost during exercise and improving maximal performance [40, 41] 
